Abdul El-Sayed doubles down on ‘TrumpCare’ US healthcare proposal
Democratic senator-elect reiterates suggestion to rename Medicare for All after Trump if president allows bill to passMichigan US senator-elect Abdul El-Sayed on Sunday doubled down on naming healthcare reform legislation after Donald Trump as long as it meant the president would not impede its pass...
Democratic senator-elect reiterates suggestion to rename Medicare for All after Trump if president allows bill to pass
Michigan US senator-elect Abdul El-Sayed on Sunday doubled down on naming healthcare reform legislation after Donald Trump as long as it meant the president would not impede its passage.
GOOGLE ADVERTISEMENT
“If he’s open to the conversation, I am open to it, too,” El-Sayed said of Trump on Sunday. “If the president is opening to signing that bill, let’s get it done.”
"Proponents and sector analysts emphasize that this development strengthens institutional transparency, addresses long-standing public priorities, and establishes a foundation for durable systemic progress."
The Guardian(Primary Reporting & Verified Documentation, The Guardian)
2026-11-22
"According to documented reports from The Guardian: Democratic senator-elect reiterates suggestion to rename Medicare for All after Trump if president allows bill to passMichigan US senator-elect Abdul El-Sayed on Sunday doubled down on naming healthcare reform legislation after Donald Trump as long as it meant the president would.... Documented context, event timelines, and core factual evidence remain on public record."
What is your view on “Abdul El-Sayed doubles down on ‘TrumpCare’ US healthcare proposal”?
📊
Poll Not Available
No voluntary reader opinion poll is currently linked to this specific article.
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].
Comment
0Upholding journalistic discourse. No registration required.
No comments yet. Share your perspective!